Table 1.
Unadjusted association of baseline characteristics with myeloperoxidase and soluble CD40L
MPO ≤ 884 pg/ mL (n = 762) |
MPO > 884 pg/mL (n = 762) |
P-value | sCD40L ≤ 989 pg/mL (n = 762) |
sCD40L > 989 pg/mL (n = 762) |
P-value | |
---|---|---|---|---|---|---|
Demographics | ||||||
Age, years | 61 (52, 69) | 61 (53, 70) | 0.60 | 61 (53, 70) | 60 (52, 69) | 0.09 |
Age > 65 years | 303 (39.8) | 306 (40.2) | 0.88 | 329 (43.2) | 280 (36.8) | 0.01 |
Female | 244 (32.0) | 259 (34.0) | 0.41 | 240 (31.5) | 263 (34.5) | 0.21 |
Risk factors | ||||||
Weight, kg | 83 (72, 95) | 83 (72, 96) | 0.72 | 83 (72, 95) | 83 (72, 97) | 0.38 |
Current smoker | 218 (28.7) | 225 (29.5) | 0.72 | 215 (28.3) | 228 (30.0) | 0.46 |
Diabetes | 191 (25.1) | 220 (28.9) | 0.09 | 191 (25.1) | 220 (28.9) | 0.09 |
History of hypertension | 512 (67.2) | 487 (63.9) | 0.18 | 492 (64.6) | 507 (66.5) | 0.42 |
Hypercholesterolaemia | 475 (62.3) | 485 (63.7) | 0.60 | 486 (63.8) | 474 (62.2) | 0.52 |
Cardiovascular history | ||||||
Prior myocardial | 303 (39.8) | 294 (38.6) | 0.64 | 287 (37.7) | 310 (40.7) | 0.23 |
infarction | ||||||
Prior heart failure | 50 (6.6) | 42 (5.5) | 0.39 | 48 (6.3) | 44 (5.8) | 0.67 |
Prior PCI | 224 (29.4) | 216 (28.4) | 0.65 | 217 (28.5) | 223 (29.3) | 0.73 |
Prior CABG | 182 (23.9) | 160 (21.0) | 0.18 | 170 (22.3) | 172 (22.6) | 0.90 |
Presenting characteristics | ||||||
Heart rate > 100 b.p.m. | 26 (3.4) | 55 (7.3) | 0.001 | 46 (6.1) | 35 (4.6) | 0.21 |
Systolic | 14 (1.8) | 23 (3.0) | 0.13 | 28 (2.4) | 19 (2.5) | 0.87 |
BP < 100 mmHg | ||||||
ST | 224 (29.4) | 233 (30.6) | 0.62 | 235 (30.8) | 222 (29.1) | 0.47 |
depression ≥ 1.0 mm | ||||||
Index diagnosis MI | 231 (30.3) | 303 (39.8) | <0.001 | 274 (36.0) | 260 (34.1) | 0.45 |
Data are shown as n (%) for dichotomous variables and median (25th, 75th percentile) for continuous variables.
BP, blood pressure; MI, myocardial infarction; PCI, percutaneous interventions; CABG, coronary artery bypass grafting.